Sino-Argi Leading Biosciences (603970) — Capital Reinvestment Ratio
Sino-Argi Leading Biosciences (603970) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥702.54 Million) in capital expenditures (CN¥139.59K). See net asset quality index of Sino-Argi Leading Biosciences to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sino-Argi Leading Biosciences Capital Reinvestment Ratio (2012–2024)
This chart tracks Sino-Argi Leading Biosciences's Capital Reinvestment Ratio across 10 annual periods. Check 603970 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sino-Argi Leading Biosciences (2012–2024)
Year-by-year Capital Reinvestment Ratio for Sino-Argi Leading Biosciences from 2012 to 2024. For live market cap and broader valuation context, see 603970 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | CN¥307.40 Million | CN¥2.18 Million | ▲ +217.1% |
| 2022 | 0.00x | CN¥1.54 Billion | CN¥3.44 Million | ▼ -81.7% |
| 2021 | 0.01x | CN¥325.42 Million | CN¥3.99 Million | ▼ -71.2% |
| 2020 | 0.04x | CN¥352.12 Million | CN¥14.99 Million | ▲ +248.8% |
| 2019 | 0.01x | CN¥218.90 Million | CN¥2.67 Million | ▼ -91.1% |
| 2018 | 0.14x | CN¥65.69 Million | CN¥8.99 Million | ▲ +28.2% |
| 2017 | 0.11x | CN¥518.83 Million | CN¥55.39 Million | ▼ -55.9% |
| 2016 | 0.24x | CN¥152.22 Million | CN¥36.85 Million | ▲ +58.5% |
| 2014 | 0.15x | CN¥40.41 Million | CN¥6.17 Million | ▲ +862.2% |
| 2012 | 0.02x | CN¥109.43 Million | CN¥1.74 Million | — |